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ABSTRACT
DIFFUSION PROBLEMS IN WOUND HEALING 
ANDA SCATTERING APPROACH TO 
IMMUNE SYSTEM INTERACTIONS
Julia Suzanne Arnold 
Old Dominion University, 2000 
Director: Dr. John A. Adam
A theoretical model for the existence of a Critical Size Defect (CSD) in certain 
animals is the focus of the majority of this dissertation. Adam [1] recently developed a 
one-dimensional model of this phenomenon, and chapters I - V address the existence of 
the CSD in a two-dimensional model and a three-dimensional model. The two- 
dimensional (or 1-d circular) model is the more appropriate for a study of CSD’s. In 
that model we assume a circular wound of uniform depth and develop a time- 
independent form of the diffusion equation relevant to the study of the CSD 
phenomenon. It transpires that the range of CSD sizes for a reasonable estimate of 
parameter values is 1mm-lcm. More realistic estimates await the appropriate 
experimental data.
The remainder of this dissertation is devoted to two phenomenological models 
describing the spread of cancer and the effects of the immune system on that spread. In 
chapter VI, Tumor Immunity, a PDE similar to Fisher’s equation is analyzed in terms of 
the equilibrium points and their linear stability and similarities are noted with the Spruce- 
Budworm problem of Ludwig et al (and summarized by Strogatz). This chapter 
concludes with a standard phase plane analysis of a traveling wave solution.
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Chapter VII, Tunneling, introduces a novel and hopefully useful way of looking at 
cancer growth and the immune system. In the governing differential equation, the 
cancer cell number represents the independent variable, while the dependent variable is 
related to the probability of achieving that size cell number. (The square of the 
dependent variable is the probability). By analogy with quantum mechanics, the idea is 
introduced that the immune system (represented by a rectangular barrier of height V) 
may not in all cases prevent the cancer from “penetrating” the barrier i.e. tunneling 
through. The governing differential equation and boundary conditions represent a 
classical eigenvalue problem which may be thought of here as a “semi-classical” version 
of the time-independent Schrodinger equation. Examples are provided which show 
considerable variation in the effectiveness of the “immune barrier” towards limiting the 
numerical growth of cancer cells.
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
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1CHAPTER I 
INTRODUCTION
Lecomte DuNouy [6] in his book Biological Time, written in 1936, wrote 
these words,
“The difference between the biological method of approach and 
the mathematical method borrowed from the physical sciences is .. .the 
multiplicity of the factors and ... the complexity of the problem. The 
solution had not yet been found, because those who had studied it were 
too familiar with the details of the phenomenon. Knowing a great many 
physiological factors but ignoring their relative influence, they did not dare 
eliminate them, and did not know how to take them into account. They 
were paralysed by their knowledge.
Like the botanist who could not see the forest because of the trees, 
they could only consider the facts as a function of microscopic biological 
elements with which they were familiar. My ignorance of these elements 
freed me from the chains which fettered them. Not knowing how to 
distinguish the different species, I examined the forest from a distance, as 
a whole and quantitatively as I had been taught to do for a physical 
phenomenon.”
DuNouy is saying that sometimes it is necessary to strip the physical situation and 
consider a mathematically manageable set of parameters and begin the investigation from 
a distance. The following information gleaned from books and papers represents the 
basic information from which the following mathematical model was formulated.
THE CRITICAL SIZE DEFECT
Part of the care a neurosurgeon or dental surgeon might give a patient is the 
treatment of bone wounds. For example, a neurosurgeon removes a portion of the skull
The model journal used is Mathematical And Computer Modelling.
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2to expose the brain. When his operation on the brain is finished, he must decide to cover 
the cavity with a plate or reposition the excised bone, suture it in the hope that it grows 
back together. An oral surgeon removes a portion of bone while excising a cancerous 
tumor in the mandible or jaw bone. Is the cavity too large for the bone to regenerate 
itself? Will he need to provide an alternative treatment to ensure that the bone will heal 
properly? When teeth are removed from the jaw bone, will the socket fill in with new 
bone? These are questions that surgeons must ask themselves routinely. Bone wounds, 
such as breaks, or gouges may at times heal naturally and at other times may not heal 
without medical treatment. In Winet [30], a critical size defect is defined as the wound 
size for which the diameter is too large for ossification (the formation of rigid bone), 
(although the wound is not necessarily circular). This means that the calcification of 
new bone ceases before reaching the opposite side of the wound, thus leaving spongy 
bone called cancellous bone in the center of the wound. The objective of this paper is to 
provide a mathematical basis for the existence of this critical size defect or CSD in bone. 
In Adam [1], a one dimensional model was used to show this existence. This paper 
extends his work into both a two-dimensional and three-dimensional setting.
The time development of the wound is not addressed here; only the conditions 
under which tissue regeneration occurs. The primary objective is to find in each case a 
critical radius beyond which no healing occurs-the definition of a CSD.
In the two-dimensional and three-dimensional setting, Model I corresponds to a circular 
cylinder, and a sphere respectively in which bone has been removed and no bone remains 
in the vacated area. In the two-dimensional problem, Model II examines the case where
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
a central core of bone remains in the excavated area. (This cannot occur in the three- 
dimensional setting.)
In each model we assume a thin ring of width 6 which influences the mitotic 
activity up to the wound edge. In the models, C(r,t) represents the concentration of a 
generic growth stimulator, R being the radius of the wound and t being time, both in 
appropriate units. For Model I, R < r < °°, and for Model II 0 < r < °°.
THE NORMAL GROWTH PROCESS IN BONE
From Bloom & Fawcett [3] we find that bone is composed of many different 
types of cells. In order for a bone to grow from “infant size” to “adult size” a process of 
growth and resorption must occur. The exterior of a bone is covered with a connective 
tissue membrane called the periosteum. The interior of the bone is made up of a cellular 
membrane called the endosteum. In the deep layer of periosteum cells are cells called 
osteogenic cells. During growth it is these osteogenic cells which proliferate giving rise 
to cells called osteoblasts. A key factor in the bone cell development are the growth 
factors secreted by these osteoblasts. Some of the growth factors secreted are named 
bone morphogenetic protein or BMP. ( There exist also BMP 2, and BMP 7). In 
addition there is a transforming growth factor beta called TGF-{J, a fibroblastic growth 
factor beta FGF-P, and others. According to Bennett et al [4], growth factors may act 
on the producer cell, adjacent cells, or distant cells. When activated these growth factors 
can stimulate a number of processes including wound healing. The osteoblast cells 
secrete the intercellular substance of bone, thus adding new bone to the surface and thus
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
4increasing the size or width of the bone. In the endosteum the osteogenic cells produce 
cells called osteoclasts which have the job of bone resorption. This in turn enlarges the 
inner shaft creating a larger bone marrow cavity. Since this procedure is part of the 
growth procedure for new born animals until they reach adulthood where this process 
then ceases, it is easy to understand why wound healing in bone in young animals may be 
more successful than in full sized adult animals. Most of the experimental research on 
the critical size defect was performed on the skull or calvaria of animals. We will now 
examine how bone wounds heal.
THE NORMAL WOUND HEALING PROCESS
When a bone wound occurs a temporary blood clot seals off damaged blood 
vessels. A fibrous protein (BMP or other growth factors) develops within the bone near 
the wound edge. This fibrous substance is referred to as collagen. As the collagen ages 
the osteoblasts start to build a spongy bone (cancellous bone) on the wound edge until it 
links the gap. Gradually denser, harder bone replaces the cancellous bone; hard bone is 
called cortical bone. In some cases the gap is too large and remains filled with a fibrous 
connective tissue which fails to calcify [3],
THE TIME FACTOR FOR HEALING
EBI Medical Systems and the Mayo Clinic Health Letter describe the time 
interval for bone healing [7,10] as follows. While the healing process begins 
immediately, the complete healing of bone may take from two months to two years.
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
5(Although according to Hollinger and Kleinschmidt [16] if a bone defect is not 
regenerated within one year it is unlikely that it will occur.) During the first few days 
after a wound has occurred, the spongy bone forms on the wound edge. Within seven to 
ten days, the gap between the new bone is invaded by embryonic tissue which forms a 
bridge of connective tissue, called fibrocartilage. This begins at the wound edge and 
moves toward the center. This generally occurs three to four weeks after the initial 
wound. In the sixth to eighth week, the process of bone resorption occurs, where the 
vascular system penetrates the fibrocartilage, breaks it down and absorbs it while 
replacing the area with fiber bone. The last phase is the change from fiber bone to a 
rigid bone.
The time-development of the healing process is not taken into consideration in 
the mathematical models that follow because the timescales justify the assumption of 
diffusive equilibrium in these models (which is discussed in Chapter II).
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
6CHAPTER II 
THE MATHEMATICAL MODELS
THE ONE-DIMENSIONAL MODEL
Adam [1] investigated the CSD phenonenon in a one-dimensional setting. The 
first model corresponded to bone removed from an infinite plane, in which only a thin 
band of tissue at the wound edges takes part in bone regeneration. The edges are
represented by x = ± y . The region [0, y  ] represents the right half of the wound
where no tissue or bone remains, and [ y , y  +6] represents the layer generating growth
factor (GF). In a second model in [1], it is assumed some bone remains in the center but 
is not a source of GF, it merely serves as a passive vehicle through which GF freely 
diffuses. Simple though these models were, they did provide some upper bounds for the 
size (width) of the CSD.
THE TWO-DIMENSIONAL MODEL
According to the work of Arnold and Adam [2] model 1 assumes a circular 
wound of uniform depth in which no bone remains in the wound interior. Model II 
assumes some bone remains in the wound center but is not a source of growth factors, 
as indicated above, and in [1]; it is essentially bone in which the GF diffuses.
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
7BASIC CONFIGURATIONS: MODEL I
We position the center of the circular wound at the origin; a disk of radius R 
being removed . As indicated earlier we suppose that a generic "growth factor" (GF) is 
produced as a result of the trauma to the system, and it is the distribution of this growth 
factor that determines whether or not wound healing occurs in this model.
The differential equation describing the space and time distribution of the growth 
factor concentration C(r,t) is
where D, A and P are respectively the diffusion coefficient for the GF in the tissue, the 
decay or depletion rate of the GF, and the production rate of GF by the enhanced 
mitotically active cells in the vicinity of the wound’s edge. These are assumed to be 
constant in both models. Furthermore, S(r) is the source term describing the distribution 
of GF production throughout the active tissue. In both models this is assumed to be 
uniform; thus
5 being the width of the active layer producing GF.
In equation (1), the first term represents the time rate of change of GF 
concentration, the second term describes the spatial change due to difliision of GF, and 
the third term is the depletion or decay rate of change of GF as it interacts with the
(I)
S(r) = lfo rR < r< _ R  + 5
S(r) = 0 elsewhere
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8system as a whole, and is changed or removed. One important assumption made is that 
of diffusive equilibrium. Basically, this means that the process of readjustment of the GF 
concentration as the wound heals is so fast (when compared with the typical wound- 
healing time) that, to a first approximation, the distribution of GF may be considered 
independent of time [1]. A typical diffusion time, from dimensional analysis is
where r is a typical wound radius. The value D depends on the particular GF (the higher 
the molecular weight, the smaller is D). Sherratt and Murray [19,20] carried out a best 
fit analysis from data on epidermal wound healing and estimated that for epidermal GF, 
D » 3.1 x IQ~7cm2 sec '1 . Diffusion processes alone will not suffice in bone to 
provide nourishment for the osteocytes, but capillaries are never far away: the 
osteocytes are arranged around central capillaries in concentric layers, which form 
spindle-shaped units known as osteons. Thus pure diffusion is facilitated by the efficient 
capillary transport system, and we might expect that the effective diffusion coefficient is 
enhanced compared with the standard value used in [1] (at least for growth factors of 
the same molecular weight). It is difficult to be more precise at this stage, but again, for 
the purposes of illustration, we suppose that, compared with the values used in [1], D is 
increased by a factor of ten. Thus we take D =3.1 * lO^cm2 sec'1. Using the first value 
for D and r values of 1pm (10"*cm), 10pm, 1mm, and 1cm we find typical diffusion 
times of .03 sec, 3.2 sec, 8.9 hrs, and approximately 37 days. Clearly the approximation 
is less well justified for GF in wound sizes of order one centimeter. Using the second
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
9value for D and r values of lgm (lO^cm), 10 pm, 1mm, and 1cm we find typical 
diffusion times of .003 sec, .32 sec, .9 hrs, and approximately 3.7 days. Over this 
timescale, the diffusive approximation is certainly a very good one for GF distributions.
dCUnder these circumstances, we write —  = 0 in equation (1).
MODEL I: EQUATIONS AND SOLUTIONS
2 *•If a  = — then equation (1) can be written as:
The boundary conditions are:
C(r) and are both continuous at R + 5
dr
lim C(r) = 0
dC(r)
— M = 0  a tr  = R. 
dr
The first two conditions are obvious requirements. The third condition implies
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
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that there is no flux (number of molecules crossing unit area in unit time) at the wound 
edge. The second model will modify this restriction as we will permit tissue in the 
wound area capable of dispersing GF.
In terms of the dimensionless variable x = ar, equation (2) becomes
The solutions to the homogeneous version of (3) are modified Bessel functions of order 
zero. After some algebra, the solution to the nonhomogeneous equation can be written, 
in terms of the original variables for R< r<  R  + 6  as
-P K ,(a (R  + 5 )) , , , -P K ,(a(R  + 8)) I,(oR) „  , . P
C ( r ) = — w.— I o ( a r ) + — w.— O T M a r ) + r  (4)
and for r  > R  + 8 as
C(r) =
•PK ,(a (R +8))  I,(aR) PI,(a(R + 8)) 
XP5 K , (a R )+ XPS
K0(ar) (5)
where ps = + K0IiX a(R+ 5)) .
For the generic parameter values P, X = I, aR = 2, and a8 = .5 a typical graph of 
C(r) is shown in Figure 1.
Using equation (4), we apply the criterion that
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
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C(R)>0
where 0 represents a threshold value for which wound healing will occur for values of r 
satisfying this condition. The resulting equation is:
P f  K , (a (R + 8))
H  '  P5
I > R )
I,(qR)K0(aR)
K.(aR)
>0 (6)
Using standard identities for the Wronskian [19], inequality 6 simplifies to
(qR-i-a5)Kl(aR  + a8) IQ 
aRK,(aR) " I _ ~P~ (7)
If aR = y and ab = e, then inequality (7) can be written as
yKt(y) P n (8)
where n = — . Holding y fixed, Q(e,y) can be thought of as a function of e= a8, from 
A»0
which we can then find a lower bound 5C (8 critical and also ec for e critical) for 
the width 8 above which healing can occur. It is not possible to obtain an explicit 
expression for ec in general, but if e is small compared with y, then we may use first 
order Taylor polynomials to simplify the Bessel functions. Thus to first order in e
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
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0.35
0.3
0.25
0.2
C (r)
C l( r l)
0.15
0.1
0.05
2.5 3.5
r .r l
Figure 1: The growth factor concentration C(r) for Model I. For illustrative purposes P 
and A = I, aR = 2 and a8=. 5. C(r) is the dotted graph representing the 
8- region, and Cl(rl), the solid graph, represents r >R + 8.
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KL1(y + e)*BC1(y) + eK;(y)
where K/(y) = _ Ko(y)_iS iM
whence
Kt(y)+E( - K 0( y ) - - ^ (y+g) .  , 1  
vK,(y)" n
which simplifies to:
s > 8 = K,(y)
nKofy)
(9)
i.e.
8 > 8 = K,(y)
anK„(y)
The graph of a5c is given in Figure 2. (See Appendix A for more information.)
With y fixed, Q(e,y) becomes a function of e. Call this function Q^e). If ec
satisfies Q,(ec)< 1--^, then any s > Sc satisfies Qt(s)< 1 - —.
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
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0.95
0.9
0.85
0.8
ec(y) 0.75
0.7
0.65
0.6
0.55
0.5
y
Figure 2: The graph of the width function ec(y) = a5c(y), defined by inequality (9). In 
this graph n = 2.
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This follows despite the fact that Kt(y + e) is monotone decreasing in e, while (y + e) is 
monotone increasing in e. The derivative of (y + E )Kt(y + e ) is 
-(y + e )Ko(y + e), hence (y + e)Kt(y + e) is monotone decreasing in e. Thus
QiCeJ > Qt(e) since ec < e  . Hence Qi(e) 5 (^ (e j < I -  ^ .
Large values of n denote an active production rate which would certainly be 
conducive to healing. Alternatively, small values of X or 0 relative to P also imply large 
values of n. In Figure 3 the graph of Qt(e) from equation (8) is illustrated for the 
parameter values y = 2 and n = 2.
A comparison of the values from the graph of equation (8) referred to as (a8c)g 
(with no approximation except rounding) and the values from equation (9) referred to as 
a5c are given in Table 1.
Using this value of 5C> a representative for - values can be sought. Using 
equation (8), we can write
Q , ( y ) . f c (10)
yK,(y) n
by s u b s t i t u t i n g f o r  e in equation (10) and simplifying the result, Q2(y) becomes 
nK0(y)
Q2(y) =
'nyK0(y)+K l(y)l f K ,(y)'-------------------- Kt y + ---------
V nyK0(y)K,(y) ) nK0(y). S ‘- i  ( i d
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e
Figure 3. The graph of the function Q,(e) defined by equation (8) with y = 2. The
parameter value is n = 2. The intersection of the dotted line with the graph of 
Qi defines the point which represents the minimum thickness of GF activity, 
below which no healing can occur for e less than this amount.
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the graph of which is given in Figure 4. The parameter value used for Figure 4 is 
n = 1.5.
Solving for y from inequality (11) is not feasible, analytically, at least. However, 
observe that the graph of Q2(y) in Figure 4 resembles that of a rational function. Thus 
by finding a rational function which approximates Q2(y), it should be possible to 
approximate by an explicit formula. A rational function which approximates Q2(y) 
for various parameter values is
F(y) = b -  -  
y
for suitable a, and b, both positive. Solving for y, the formula for af^ = yc is
an
•048
In Figure 5, for n = 1.5 F(y) = 523  -----
y
and y =.253 while graphical methods give y =.252. Some additional comparisons are 
given in Table 2.
An interesting observation is that using the minimum value for a8c will always 
produce a CSD because of the dependence on n in the equation. (See equation (11)). 
For n very large, e.g. n = 200, the graph of equation (11) is shown in Figure 6.
If we choose an a6 > a6c such as ~ ~ T ^ or P * 1, it is possible to create graphs
(y)
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Table 1. For various values of n and ceR, a comparison is made between the
approximation for the a8c region and the values found on the graph of
Q,W
n 1 - 1/n aR a8c ( afijg - a8e
1.5 .33333 1 .95 1.39 .44
1.5 .33333 3 .77 1.22 .45
1.5 .33333 5 .73 1.15 .42
1.5 .33333 7 .71 1.16 .45
1.5 .33333 10 .70 1.16 .46
1.5 .33333 20 .68 1.13 .45
5.0 .8 1 .29 .307 .017
5.0 .8 3 .23 .253 .023
5.0 .8 5 .22 .244 .024
5.0 .8 7 .21 .235 .025
5.0 .8 10 .21 .235 .025
5.0 .8 20 .20 .226 .026
8.0 .875 1 .18 .190 .01
8.0 .875 3 .14 .154 .014
8.0 .875 5 .14 .145 .001
8.0 .875 7 .13 .145 .015
8.0 .875 10 .13 .140 .01
8.0 .875 20 .13 .137 .007
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0 0.2 0.4 0.6 0.8 1
y.y
Figure 4: The graph of Qz(y) where the approximation ec(y) replaces e in Q(e,y). For 
this graph n = 1.5 .
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0.5
0.45
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Q 2(y)
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Figure 5: The graph of Figure 4 and its rational approximation F(y). For this graph 
n= 1.5, a = .048, and b = .523.
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Table 2. For various values of n, aR^ values are found.
n
. - In
(aRc)g a b
1.1 .091 .13 .155 .050 .413
1.5 .333 .252 .253 .048 .523
3.0 .667 .40 .480 .029 .727
5.0 .800 .45 .487 .014 .829
8.0 .875 .54 .572 .010 .892
10 .900 .54 .539 .008 .915
20 .950 .59 .670 .002 .952
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which show no CSD is possible. For example; for n = 2 and P; = 1, 1.2, and 2 for 
i = 0,1, and 2 respectively, Q^y) is defined as follows:
Q„(y) =
'nyK 0(y )+ p iK,(y)>
nyK0(y)K1(y) ( 12)
(which is true from an earlier conjecture). The corresponding graphs are given in 
Figure 7. Thus using an a8 value larger than the minimum illustrates a situation 
modeling complete healing. For p = 1, Q20(y) represents ec substituted for e. For 
P = 1.2, Q2i(y) represents a situation which shows the existence of a CSD. For P = 2, 
Q22(y) is exhibiting a graph with no CSD which implies complete healing. An 
examination of the asymptotic expansions of the Bessel functions reveals that when
P = 1, lim Q2(y) = 1 for all n. It follows that the graph of Q2(y) will asymptote to the
y -» co
horizontal line y = I and thus exceed 1 -  ^  for sufficiently large y. Since equality in 
equation (12) indicates the existence of a CSD, this proves that there is always a CSD
when P = 1.
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y
Figure 6: Figure 4 reproduced for n = 200. The purpose of this graph is to illustrate the 
existence of a CSD when the minimum value a6c(y) is substituted for e.
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
24
0.7
0.6
0.5
Q22(y)
0.2
0 0.5 1.5 2 Z5 3
y
Figure 7: For n = 2, and P a  constant multiple of e(y), Q20(y) represents a8c substituted 
for e which means P = 1. For p = 1.2, Q21(y), by intersecting with 1 - 1/n, 
exhibits a CSD, and for P = 2, Q^Cy) shows no CSD.
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MODEL H: EQUATIONS AND SOLUTIONS
In this model, there is still some tissue in the wound interior for r < R. It is 
merely a passive environment into which GF can difliise. As before, the ring from the 
wound edge at R to R + 8 is the domain of GF production. Additional boundary 
conditions need to be imposed:
dC(r)
continuity of C(r) and—-—  at R, and C'(0) = 0.
dr
The corresponding solutions are:
C(r)= AI0(ar)+ B K 0(ar) for r < R
P
C(r) = MI0(ar) + NK0(ar) + — for R_< r < R + 8
A,
and C (r)=G K o(ar) for r > R + 8.
Let P = ( l 0K, + K0Ij)(ar) and p5 as before, then
P f K,(qR) K ,(a(R+8))'
I0(ar) forr<R, (13)
^  V P P5 j
P
K0(ar) + — f o r R < r < R  + 5 (14)
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and
-P
C (r) = T
I,(gR) _ I,(g(R+8)y
P Ps ,
K0(ar) fo r r> R  + 5 (15)
A typical graph of C(r) using parameter values P, X = 1, aR = 5, and a6 = 3 is 
shown in Figure 8.
The requirement C(R) > 0 implies, from equation (14) that
a l R + S j K ^ a C R  + S ^ I o C a ^  + aRI^aRjK oCaR)^  1 - - .
n
Again if e = a5 and y = aR then the above equation becomes
Q(e,y) = (y  + e)Ki(y + O M y ) + yIi(y)Ko(y) ^ l -  -  (i6)n
the graph of which is given in Figure 9, using parameter values n = 3 and y = .5.
By similar methods to those used in Model I, we can find an approximation for
6C under the assumption that «  1. This is£ > $  -i  the graph of
*  '  c nayK0(y)I0(y)
which is given in Figure 10 (for n = 3 ).
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
27
0.9
0.8
0.7
0.6
0.5
C2(x2)
0.4
0.3
0.2
0.1
Figure 8: The Growth Factor Concentration C(r) for Model II: (C,(xl) is defined over 
[0,R], C2(x2) is defined over [R,R+8], and C3(x3) is defined over [R+8,°°]).
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Figure 9: This is the graph of Q^e) from equation 16 with y = .5. The parameter value 
used isn = 3.
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Again substituting ec from equation (17) for e in Q(e,y) we obtain the function 
Q2(y) whose graph is given in Figure 11 for the parameter value n = 3. The rational 
function F(y) which closely approximates
Q2(y) = y+
i
BC y + -
1
nyK0(y)I0(y)J V nyK0(y)I0(y)J i0(y) + yii(y)Ko(y)
by
with n = 3 is F(y) = - ^  for b = .765 and c = .059 (see Figure 12). As in Model I,
lim Q2(y) = 1. This guarantees a CSD for all n > I.
y —
by I
The explicit formula for y from < 1 — — is
c+ y n
c -  cn
=  < » >
(In Table 3 where the (a6c)g values from the graph show none, the entire graph lay 
above 1-l/n). Table 4 shows values for aRj found in like manner as Model I.
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Figure 10: This is the graph of ec(y), which represents the 8 region of the wound, for 
n = 3.
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Figure 11: The graph of Q2(y) for n = 3 which shows the existence of a CSD.
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Figure 12: The graph of Figure 11 and its rational approximation function F(y). For this 
graph n = 3, b = .765, and c = .059.
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Table 3. For various values of n and aR, a comparison is made between the
approximation for the a6c region and the values found on the graph of
Q(
n i - in
aR a6c ( « 6 c)g (a5Jg- a6c
1.5 .333 I 1.251 2.58 1.329
1.5 .333 3 1.611 none
1.5 .333 5 1.326 none
1.5 .333 7 1.330 none
1.5 .333 10 1.332 none
1.5 .333 20 1.333 none
5.0 .8 1 .3750 .4 .025
5.0 .8 3 .3930 .47 .077
5.0 .8 5 .3980 .49 .092
5.0 .8 7 .3990 .5 .101
5.0 .8 10 .3990 .5 .101
5.0 .8 20 .3990 .5 .101
8.0 .875 1 .2340 .25 .016
8.0 .875 3 .2460 .27 .024
8.0 .875 5 .2490 .28 .031
8.0 .875 7 .2490 .28 .031
8.0 .875 10 .2500 .28 .230
8.0 .875 20 .2500 .29 .040
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Table 4. For various values of n, aR,. values are found.
n 1I - -
n
W g aR, b c
1.1 .091 .116 .072 .597 .4
1.5 .333 .237 .240 .639 .22
3.0 .667 .4 .398 .765 .059
5.0 .800 .480 .466 .845 .026
8.0 .875 .51 .543 .899 .015
10 .900 .53 .585 .909 .006
20 .950 .56 .598 .952 .0015
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THE THREE-DIMENSIONAL MODEL
This simple three-dimensional model of wound healing extends earlier work [1] 
and [2] to three-dimensional spherical geometry, i.e. the case of the entire removal of a 
spherical portion of bone. However, assuming uniform GF concentration emanating 
from the wound margins, we will assume an entire sphere in our efforts to find the 
critical radius beyond which no healing occurs.
As before the time-development of the wound is not addressed. We examine the 
wound size under which full bone regeneration does not occur under the assumption of 
diffusive equilibrium (as explained earlier). Thus, in this model we assume the existence 
of a thin spherical shell of width 8 which influences and directs the growth hormone 
activity up to the wound edge. In the discussion that follows, C(r,t) represents the 
concentration (i.e. molecules/unit volume) of a generic growth stimulating factor, where 
R < r < «. R is the wound radius, and t is time, both in appropriate units.
BASIC CONFIGURATIONS:
Centered at the origin a wound sphere of radius R is removed . As indicated 
earlier we suppose that a generic "growth factor" (GF) is produced as a result of the 
trauma to the system, and it is the distribution of this growth factor that determines 
whether or not wound healing occurs in this model.
The differential equation describing the space and time distribution of the growth 
factor concentration C(r,t) is
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where D, k, and P are respectively the diffusion coefficient for the GF in the tissue, the 
decay or depletion rate of the GF, and the production rate of GF by the enhanced 
mitotically active cells in the vicinity of the wound edges. These are assumed to be 
constant. As before, S(r) is the source term describing the distribution of GF 
production throughout the active tissue, assumed to be uniform; thus
6 being the width of the active layer.
In equation (19), the time rate of change of GF concentration is not included 
because we are invoking the diffiisive equilibrium approximation; full details and the 
justification for this can be found in [1]. The first term describes the spatial change due 
to difiiision, and the second term is the depletion or decay rate of GF as it interacts with 
the system as a whole, and is changed or removed.
EQUATIONS AND SOLUTIONS:
Ifar2 = -j- then equation (19) can be written as:
S ( r )  = 1 for R< r< R + S
S( r )  = 0 elsewhere,
D
d2C(r) 2 dC(r) 
dr2 + r dr (20)
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The boundary conditions are: 
dC(r)
• C(r) and — -—  are both continuous at R + 6 
dr
lim C (r) = 0r-*«
dC(r)
dr
= 0 at r = R
Writing C(r)= Y(r)r~ , equation (20) simplifies to
d2Y(r) , -P
- ^ T - « 2Y ( r ) s -  S(r) (21)
The homogeneous solutions can be written in terms of hyperbolic function, i.e.
x sinh(ar) cosh(ar) P 
C(r) = A  — ~ +  B  — L + T  for R < r < R + 5 (22)r r A.
where
sinh(a (R  + 8)) -  cosh(a (R  + 8 ))(a (R + 8) + 1)
A =
a ( l -  A)
aR cosh (aR )-sm h (aR )
with A = _  . w  --------———  and B = - A A  Also,
aRsinh(aR ) -  cosh(aR)
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= p sinh(aR) + g cosh(aR)
(23)r r
for r > R + 5 where,
- P f cosh(a(R  + 5))(a(R  + 5) + A) -  sinh(a(R  + S))(a(R+ 5)A + 1)
X w a ( l - A )
and G = - F.
For the parameter values P,A = 1, aR = 2, and a5 = .5 the graph of C(r) is shown in 
Figure 13. (Cl(rl) represents equation (23)).
Using equation (22), we apply the criterion that C(R) > 0 where 0 represents a 
threshold value above which wound healing will occur for values of r satisfying this
0)1
condition. For n = — , and using the non-dimensionalized variables y = aR and 
e = ad, the resulting equation is
[cosh(y + s ) -  sinh(y + s)](y + e + l)  ^ QX  ^ 1 
(y+s)[sinh(y)-cosh(y)] P n
(24)
which simplifies to
(25)
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Figure 13 : The Growth Factor Concentration C(r), for parameter values P, k =1,
aR = 2 and a5 = .5 . C(r) is defined over [R, R + 8] and C l(rl) is defined
over[R+8, oo].
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whose graph is given in Figure 14 for the values y = .5 and n = 3. 
Approximating e~Eto 0 ( e 1) results in the inequality
S> s  = z±l
ny
(26)
The graph of ec(y) is given in Figure 15 for n = 3.
Note that if e = a5c satisfies inequality (25), i.e. Qt(e) < 1 - —, then e > e6
n
satisfies Q(e) < I — . This follows despite the fact that e* is monotone decreasing in n
y  + 8 + 1
e while —  is monotone increasing in e. The derivative of e"
i+.y
y+ e+ I
I + y is
-  ( v + s)~------ , hence e"
v ’  1 + v
y+ s + 1
l + y
is monotone decreasing in e. Thus Q(ec) > Q(e)
since ec < e.
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Figure 14: This is the graph of Q,(e). The parameter values used are y = .5 and n
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Figure 15: The graph of the approximation function ec(y). In this graph n = 3.
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A comparison of the values from the graph of equation (25) referred to as 
(a8c)g (with no approximation except rounding) and the values from equation (26) 
referred to as a5e are given in Table 5.
In Figure 16 the graph of Q2(y) is formed by replacing e in equation (25) with 
the approximation for ec given in equation (26). The parameter value used for 
Figure 16 is n = 3.
Using this value of ec, a representative for aR,. (which is yc) can be sought. 
Using equation (26). We can write
y*l
Q2( y ) = e ' ny 1 + nyj
1
<  1- -  
n
(27)
-3 \ , . . . . . .  y "Approximating e* to 0(e ) and substituting from equation (26), resulted
ny
in the rational expression
r{ , (y + l)[(3n2 -  n)y3 + (3n2 f n -  l)y2 + (2n -  2)y -  1 _
(y) = - 0 (28)
whose positive solution is
- 2 ( n -  1)
< V =y,
3at
i
A 5
•+ A 3 -  ■
3aj
(29)
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Figure 16: The graph of Q2(y) for n = 3 showing the existence of a CSD.
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Table 5. A comparison is made between the approximation for the a8c region and the
values found on the graph of Q( adc) for various values of n and aR.
n 1 - 1/n aR “8C (“SJg (a5c)g- adc
1.5 .3 1 1.333 1.72 .39
1.5 .3 3 0.889 1.41 .53
1.5 .3 5 0.800 1.35 .55
1.5 .3 7 0.762 1.23 .47
1.5 .3 10 0.733 1.20 .47
1.5 .3 20 0.700 1.23 .53
5.0 .8 1 0.400 .410 .01
5.0 .8 3 0.300 .310 .01
5.0 .8 5 0.240 .250 .01
5.0 .8 7 0.229 .250 .021
5.0 .8 10 0.220 .240 .02
5.0 .8 20 0.210 .230 .02
8.0 .9 1 0.250 .252 .002
8.0 .9 3 0.166 .177 .011
8.0 .9 5 0.150 .160 .001
8.0 .9 7 0.143 .152 .009
8.0 .9 10 0.137 .140 .0105
8.0 .9 20 0.131 .140 .009
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where ax = 3n z -  n  ; a2 - n  -  3n2 -  1; a 3 = 24w4 -  80«3 + 165«2 -  42n + 5
and A =
2(n- l )a2 i 1 
6at2 2a! 3a J 6n(3n- 1)2 •
(See Appendix B for a detailed explanation of the choice of 0(e3).)
The two graphs, Q2(y) and F(y) are shown in Figure 17. The graph of F(y) reveals only
one positive y value at 1 -— . The parameter value used was n = 3.n
-i
Some additional comparisons are given in Table 6. Since lim Q2(y) = e " and
y—x jo
—  i
lim  e "  = 1, it follows that Q2(y) will always intersect 1- for all n >1, and thus 
n-»oo n
-  1there will always exist a CSD. This follows from the fact that e n > 1 -  — for n > 1.
n
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Table 6. For various values of n, ccR^  values are found by graphical and approximation
methods.
n 1 - 1/n W g («RJ
1.1 .091 .32 1.515
1.5 .333 .54 1.167
3.0 .667 .78 .909
5.0 .800 .86 .905
8.0 .875 .92 .93
10 .900 .93 .941
15 .933 .96 .959
20 .950 .96 .969
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Figure 17: This shows the comparison of Q2(y) and the approximation function F(y) for 
n = 6.
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CHAPTER m  
PARAMETER ESTIMATES
Some reasonable values for the parameters P, k, 0 were found in [1] to be as 
follows: k = 1.6 x 1 O'5 sec'1 (based on Sherratt and Murray’s [24, 25] work that the
estimated half-life of chemical decay is about 12 hours and thus, k = —  hr'1 which12
yields the preceding value). The value for D, the diffusion parameter, depends on the 
particular GF or enzyme in general and the medium in which it is diffusing. The higher 
the molecular weight, the smaller is D. However some indication of this can be found by 
considering the diffusion of oxygen and sucrose in water. At a temperature of 25 °C, D 
= 2.4 x 10'5 cm2 sec'1, while for sucrose at 20°C, D = 4.6 * 10"6 cm2 sec'1 [8], Sheratt 
and Murray [24, 25] carried out a best fit analysis from data on epidermal wound healing 
and estimated that for epidermal GF, D « 3.1 * 10'7 cm2 sec'1, which is considerably 
smaller because of the high molecular weight (about 6000, see Ruddon [22]). In their 
papers they also considered growth inhibitors, for which D » 2.4 * 10'5 cm2 sec'1. Thus 
it seems not unreasonable to take a value of D ~ 5 * 10'7 cm2 sec1 for GF [1,2].
In earlier work [1] a value for a was estimated from entirely phenomenological 
considerations for illustrative purposes. The basis for this estimate was soft tissue data, 
and yielded a  =6 cm'1. Clearly the CSD phenomenon is confined to bone, and it is
reasonable to ask what range of a-values might be appropriate. Since a  = .1— this is
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equivalent to asking how both X and D change from soft to hard tissue environments. 
Unfortunately, this data, if known at all, is difficult to come by. The best that can be 
done at this stage is to make some plausible estimates of their orders of magnitude.
Diffusion processes alone will not suffice in bone to provide nourishment for the 
osteocytes, but capillaries are never far away: the osteocytes are arranged around central 
capillaries in concentric layers, which form spindle-shaped units known as osteons. Thus 
pure diffusion is facilitated by the efficient capillary transport system, and we might 
expect that the effective diffusion coefficient is enhanced compared with the standard 
value used in [1] ( at least for growth factors of the same molecular weight). Concerning 
the decay coefficient X it is even harder to speculate. Given the increased average 
density of bone compared with soft tissue, the effective decay of GF may be hindered 
somewhat (i.e. X reduced). It is difficult to be more precise at this stage, but again, for 
the purposes of illustration, we suppose that, compared with the values used in [1], X is 
halved and D is increased by a factor of five. Thus we take A.=8 x 10"6 sec'1 and D = 2.5 
x 1CT6 cm2 sec'1. This results in a value of a =1.8 cm'1 It can be seen from column 4 in 
Table 2 and 4 in this chapter that the dimensionless quantity a l^  ranges from about 
0.04 to 0.37; for the above value of a  this corresponds to in the range 0.8 mm to 7.4 
mm which is certainly of the right order of magnitude for the lower end of the CSD sizes 
quoted above corresponding to a diameter range of 1 mm - 1 cm. Similarly, for the 
three-dimensional case, the values of aR,. from Table 6 column 3 range in value from .32 
to .96. Using the value 1.8 for a„ 1^ ranges from. 18 cm to .53 cm or diameter range of 
3.6 mm to 10.6 mm. It must be emphasized however that our values for a  are only as
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valid as the values for X and D, and these are estimated. Clearly, quantitative validation 
of the consistency of the models in this chapter must await measurement of these 
parameters based on experimental data.
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CHAPTER IV 
RELEVANT EXPERIMENTAL DETAILS
According to Frame, [12] bony healing was studied in skull cavities with 
diameters of 5, 10, 15, and 20 mm on a crossbreed rabbit of New Zealand reds and half 
lops. The age of the rabbits used ranged from 6 to 10 months. Weights of the rabbits 
were between 3 to 4.8 kg. The rabbits underwent a surgical procedure, where using a 
dental handpiece called a trephine, a spherical hole was removed from the skull of the 
rabbits. Four groups were formed with four animals in each group. The group was 
determined by the diameter of the wound (i.e. 5, 10, 15, and 20 mm diameters). The 
animals recovered without problems from their operation. The experimenters were not 
concerned with the rate of healing, but whether bony bridging of the defect would occur. 
Only one time interval of 24 weeks was chosen, after which the animals were killed and 
their skull removed. The 5 mm holes were filled with new bone that bridged the gap, 
with loss of definition of the original margin. In some, the new bone was the same 
thickness as the adjacent skull. Marrow spaces were present in the new bone. The 10 
mm group had bone filled cavities and only a few uncalcified areas. The new bone 
formed at the margins was thinner than the adjacent skull, and several isolated spicules 
were present. The bony bridge was incomplete in places, the gaps being filled with a 
layer of dense fibroconnective tissue. Marrow spaces were seen. The 15 mm group had 
ill defined growth. New bone had formed at the periphery and on isolated islands. The
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new bone was thinner at the margins than the surrounding skull. Fibrous connective 
tissue filled the gap and some spaces were filled with marrow. In the 20 mm group, all 
specimens showed no bony bridging and a central uncalcified area. Some bone had 
formed at the margins, and as isolated islands. They concluded that the most suitable 
size of osseous defect was the 15 mm diameter. Another four rabbits with 15 mm 
defects were followed up after 36 weeks and compared with the 24 week group. The 
result was very similar. New bone had formed mainly at the margins of the defect, often 
as isolated islands, and the gap was filled with dense fibrous tissue. Radiographs 
showed no significant amount of new growth formed.
Another experiment using the trephine in the Rhesus monkey was detailed in 
Ferguson et all [9], Cranial defects measuring 14-20 mm in diameter were created in 
Rhesus monkeys. In the experiment, there was one control defect and one experimental 
defect. The control defect was implanted with bovine serum albumin (BSA), and the 
experimental defect was implanted with 100 - 200 mg of a partially purified bovine bone 
morphogenetic protein (bBMP). After 16 weeks, the control defect consistently showed 
only fibrous connective tissue in the wound, while the BMP defect had progressive 
growth of new bone which filled the defect. Hollinger et al [16] also did experiments 
with bony repair materials on 15 mm baboon calvaria. They invaded the control sites 
after 2 months to find bone being made althought not completely healed. Hollinger 
concluded that this was not necessarily a CSD since a longer interval than 2 months 
might have showed different results.
Prolo et al [21] found 20-mm defects in the calvaria of mongrel dogs. Urist [29]
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agrees with this finding. Pigs have been used in some studies [16]. Lange et al [18] used 
a volume defect of 6, 8, and 12-cc size in the femora of adult formed pigs. There were 
two groups, a control group and a group whose defect was filled with tricalcium 
phosphate. After 9 months, the defect had healed but with only half the amount of bone 
as the group that had the tricalcium phosphate.
The one group for which their is little data is humans. According to Hollinger et 
al [16], a German group is trying to incorporate humans in the testing of bone repair 
materials. Hollinger sites that neurosurgeons routinely make defects when entering the 
skull. Either the defect is left alone, or a bone repair material, such as ceramic or plastics 
is used to fill the space, - no bony healing occurs in this case. Prolo et al [20] showed 
that freeze-dried allograft plugs aided the hole in filling with new bone. In this article no 
data was given on the size of the defect. However, reference was made to the tooth 
socket as being a possible place to test bony repair materials. This gives us an idea of the 
size and shape of the defect which could be under consideration. Thus a laterial incisor 
(an average size tooth) when extracted would leave a hole approximately .32 cm with a 
diameter of roughly .75cm.
Many experiments on wound healing have been done on rats, rabbits, and dogs, 
but not much literature has been written on experiments for monkeys or humans. From 
the literature which we do have, the wound was created in the calvaria, which is the 
bony part of the cranium from the base of the skull to the forehead. In [21], Prolo 
implies that humans do not react the same as other animals to calvaria wounds because 
of a poorer blood supply in the calvaria and some deficiency of bone marrow. This
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seems to imply that the experiments on the lower mammals may not extend in the same 
manner to humans. Freeman and Turnbull [13, 28] were the first to attempt the study of 
CSD's in rat calvaria. In a 500 mg Wilstar albino rat they studied a 2 mm-diameter CSD, 
which failed to heal in 12 weeks. Mulliken and Glowacki [19] and Glowacki et al [15] 
found 4 mm-diameter to be the CSD in young (28 days old) Charles River rats. Tagaki 
and Urist [26] found 8 mm-diameter to be the CSD in 6 month old Sprague-Dawley 
rats. It did reduce to 5 mm-diameter in four weeks, but no further healing was noticed at 
the end of 12 weeks. Kramer et al [17] experimented on the calvaria of 6 to 10 pound 
New Zealand White rabbits. They found 8 mm-diameter CSD's occurred at various 
periods up to 16 weeks. Frame [12] worked with a crossbreed of New Zealand White 
and Half Lop rabbits. He made 5, 10, 15, and 20 mm-diameter wounds in the calvaria of 
these 6.6 to 10.5 pound rabbits. At 24 and 36 weeks, the 15 mm-diameter wound had 
created the fibrous connective tissue but continued to retain a central uncalcified area. 
Friedenberg and Lawrence [14] described the wound healing experiments with mongrel 
dogs. A 17 mm-diameter had less than 40% osseous repair at 20 weeks. Prolo et al [21] 
found that a 20 mm-diameter in mongrel dogs healed 20% by 6 months. Urist [29] also 
suggested that 20 mm-diameter was a reasonable CSD in dogs. These experiments show 
us that there is a critical size defect, in the general range of 2 mm - 2 cm. A summary of 
the experiments is given in Table 7.
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Table 7. Summary of research experiments on Critical Size Defect taken in part from
Schmitz and Hollinger [23],
ANIMAL Weight of 
Animal
Estimated CSD Time Interval of 
Study
Rat calvaria 500 mg 8 mm 9-12 weeks
Rabbit calvaria 8 lbs 15 mm 24 weeks
Dog calvaria 60 lbs 20 mm 24 weeks
Dog mandible greater than 20 mm 24 weeks
Monkey calvaria 20 mm suggested ??????
Monkey mandible greater than 20 mm 
suggested
??????
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CHAPTER V 
CONCLUSIONS ON WOUND HEALING
When a bone wound occurs, the body produces electrical signals that stimulate 
growth hormones in the bone. These growth hormones, which we have called growth 
factors, trigger the natural healing process. For reasons which are poorly understood, 
sometimes bone wounds fail to heal properly. Our mathematical model demonstrates 
why this may occur. Obviously there are many factors affecting these nonunions, but one 
observation relating to human subjects is that older subjects may not heal as well as 
younger subjects because older subjects may have other health challenges, which 
complicate the healing process [5], The mathematical model indicates that there exists a 
lower bound value for the width of the growth hormone region, and if that width is no 
less than this value then the GF concentration is such that healing may ensue. This by 
itself does not ensure complete healing, but that some healing will occur. In this model 
we have shown the dependence of the GF region on the original size of the wound. This 
region is limited in size by the calvaria of the animal available to stimulate the GF region. 
Large wounds may not have enough GF to stimulate complete healing, (i.e. C(R) < 0 ).
It may also be the case that due to the long time interval (several weeks to years) needed 
to complete the healing process, the GF region may not be stimulated adequately. 
According to both models I and II, sufficiently large wounds do not have enough GF in 
proximity to the wound center and to the edge to stimulate and maintain healing growth,
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and thus complete the healing process. This creates the CSD.
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CHAPTER VI 
TUMOR IMMUNITY
In these next two chapters the focus is shifted to an analysis of some simplified 
models of cancer growth and the part the immune system plays in inhibiting that growth.
THE SCIENCE OF IMMUNOLOGY
The word immunity originally meant that an individual was free from infection. 
At present the science of Immunology encompasses such a broad area that sub­
classifications such as tumor immunity, transplantation immunity, clinical immunology, 
autoimmunity and immunohematology are commonly used. In this paper, the focus is on 
tumor immunity i.e. how the immune system responds to tumor invasion.
HOW THE IMMUNE SYSTEM WORKS
In the paper The Immune System-How It Works, published by the National 
Institute of Health and the National Cancer Institute [32], it is pointed out that the 
organs of the immune system consist of not only the white blood cells, located in the 
bone marrow, but also the lymphoid organs such as, the tonsils and adenoids, the thymus 
where lymphocytes (small white blood cells) known as T cells mature, the spleen, the 
appendix, the lymph nodes located in the neck, armpits, abdomen and groin, and 
lymphatic vessels ( similar to blood vessels). The immune system stockpiles, in the
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
60
various above locations, larger groups of lymphocytes and also cell-devouring 
phagocytes. In order to have enough room for all the cells needed to attack the million 
or so types of enemy cells, the immune system stores just a few of each kind. When an 
antigen (any cell which triggers an immune response) appears, those few matching cells 
replicate until their job is done.
According to the U.S. Department of Health and Human Services publication on 
Immunology And Its Role In Disease And Health [31], the immune system is very 
complex. There is strong evidence that effector cells or lymphocytes (small white cells 
that are normally present in the blood and in lymphoid tissue) react not only against 
established tumors but that they play a major role in eliminating many tumors before 
they are able to get established. The lymphocytes eliminate thousands of cells daily 
which have undergone mutation within our bodies. Why then do individuals develop 
cancer? One answer may be that while the lymphocytes are there and able to destroy 
tumor cells, cancer patients have within their blood elements called “blocking factors” 
which contain antibodies containing tiny fragments of the tumor cell. Thus the patient 
has two competing forces at work: the lymphocytes which have the ability to kill the 
cancer tumor and blocking factors which prevent the lymphocytes from doing their job.
In the book Genes And The Biology o f Cancer [35], the statement is made that 
“Cancer is a single disease and it is a hundred diseases. The unifying aspect of cancer is 
uncontrolled growth - the appearance of disorganized tissues that expands without limit, 
compromising the function o f organs and threatening the life of the organism”. Different 
types of cells can produce different types of cancer with their own growth rate. In I
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Immunology [31], it states that research shows it is possible for the immunological 
system of a mouse to destroy millions of tumor cells in less than 48 hours. Thus, the 
more tumor cells present, the more expeditious the destruction process. A similar 
example in humans is the swiftness with which multiple warts on the hands or feet vanish 
once one of the warts is successfully attacked.
WHY DOES THE IMMUNE SYSTEM SOMETIMES FAIL TO PREVENT 
CANCER?
There are several possibilities which may prevent the immune system from 
completely assaulting tumor cells in humans. According to Immunology [31] they are:
• Blocking antibodies or antibody antigen complexes in serum prevent the 
lymphocytes from bombarding the tumor. (An antigen is any substance which 
provokes an immune response when introduced into tissue. Antibodies recognize 
antigens through surface characteristics of the foreign substance, especially by 
the electric charge, or by the pattern or shape. To unite with the antigen, the 
antibody must be exactly the right kind or specific - a term referring to the 
selective reaction which occurs between an antigen and its corresponding 
antibody or lymphocyte.)
• The patient with an antigenic tumor does not have the applicable immune 
response genes, i.e. he lacks the genetic capacity to react against his own tumor 
antigens.
• The tumor liberates substances (e.g., viruses or enzymes) which interfere with
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the immunological system.
The patient has made the wrong kind of immune response, i.e. a humoral 
response (production of antibody molecules which bind the foreign substance) 
instead of a cellular response (mobilizing cells which can specifically react with 
and destroy the invader).
• The patient may be unable to mobilize his effector cells, so that they remain
locked up or sequestered in the lymphoid organs, never reaching the cancer site. 
The patient may be tolerant to the tumor antigen.
Experimental evidence is available to support each of these possibilities and it is 
suspected that each of these factors may be acting within the patient to different degrees.
THE MATHEMATICAL MODEL
Following Edelstein-Keshet [8], we utilize a one-dimensional reaction-difiusion 
partial differential equation to mimic the tumor/immune system interaction for our 
model, because populations of tumor cells are rarely distributed uniformly within their 
environment. Their motion, migration, and redistribution are of primary interest. 
Normally we assume a continuous function and distribution to depict discrete cells 
which leads to partial differential equation models that are similar to classical models for 
molecular diffusion.
Historically, biological models involving partial differential equations date back 
to the early 1900's with work done by K. Pearson and J. Blakeman. In thel930s R. A. 
Fisher applied partial differential equations to the spatial spread of genes and diseases.
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Many partial differential equation models cannot be solved analytically in closed 
form. This is especially true of the nonlinear equations. A standard first approach is to 
reduce the problem to one that can be solved, generally by converting the partial 
differential equation to ordinary differential equations that describe some simpler 
situation. Two types of solutions are then possible: steady-state distributions and 
traveling waves.
The mathematical model under investigation is one based on a model in an 
entirely different context, namely the spruce-budworm model in ecology [39], In this 
model we include both the tumor growth of cancer and the attack on the tumor by the 
immune system. Let us consider the one dimensional problem of a long narrow tube 
through which the cancer cell concentration C travels i.e. [0,®]. In Strogatz [39], the 
problem of the population dynamics for the spruce budworm has been analyzed from 
which we wish to adopt his findings to the cancer-immune problem. We will consider 
the partial differential equation
8C n d C _ —  = D — =-+a C 
dt dx2
yC2
V. P J v|/ + C
(30)
where the first term is the time rate of change of cancer cell concentration C. The 
second term is the diffusion coefficient and spatial change. The third term is the logistic 
term representing cancer growth and the last term is the immune response term which 
models the destruction of cancer cells. The parameters a, P, represent the growth rate 
of the cancer cells, and the carrying capacity of the population respectively. The
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parameter y is the rate of mortality due to predation by the immune system, while Y 
represents the speed with which the immune system reaches its maximum rate of 
mortality. All of the parameters are positive. We will nondimensionalize equation (30)
by letting Y(x,t) = ^  ^ ^ g  ^  y Thus,
3 C 3 7  _ dY_ 
dY dt '  V dt and
d2Y _  d C  
dx2 dx2
Substituting in (30) we obtain
d Y  d 2Y
1 -
\|iY 2 ... 2
2 v2\|/ + v|/ Y
Dividing by y yields
\|i d Y  d 2Y  \|/ „
— ~  = D — ~ z ~ Y  + ct— Y  
y d t y dx  y
1 -
»i/r
l + r
(31)
y t    w _  au/ — (3
Let t  = —  , D = D— , a = — , and 0 = — 
V y y y
then (31) becomes
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(32)
Let (33)
In a first analysis we focus on g(Y). The idea in the first instance is to replace g(Y) by 
its linear Taylor approximation about each fixed point (or equilibrium point).
ANALYSIS OF THE FIXED POINTS
g(Y) has a fixed point at Y = 0 which is unstable because g '(Y ) > 0 (see Figure 18).
Intuitively the cancer population is so small that it seems non-threatening and so the 
cancer grows exponentially for Y near zero. g( Y) = 0 also yields either 3 or I real
positive root upon solving the expanded and simplified version of equation (33), (see 
Figure 18), which is
Let Iq, = 0, and lq, for i = 1, 2, 3 be the possible 3 roots of equation (34). They are 
found to be
a Y 3 - ( f p Y 2 + (a"+ p ) 7 - a p  = 0  . (34)
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g(y)
v
Figure 18: This graph shows the four roots of g(Y). We can see that the derivative of 
g(Y) is positive at Y = 0 and at the second positive root which is the 
definition of unstable fixed points. In this figure a  = .5 and (3 = 1 0 .
k , - p + ± F
k, = - 5 P - i V 3 ( M
l (a + P ) _ I p
3 a 9 P 
M *
and
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k 2 = -.5 P+iV3(M-
i (q + P) i p
3 a 9 P 
M + , where
N  = V 4 a 3 + 1 2 a 2P + 8 a 3p 2 + 1 2 a p 2 -  2 0 a 2p 3 + 4a  3p 4 + 4 p 3 -  a 0 4
M =
-1  (a + P) -  1 -  1 - ,  1 V3
— — _  — B + - B  + —  P + —  N - V  
6  a M 2 V 2 7 H 18 J -
a 2 .
and
P= M -
1 (oc + p ) 1 —2
3 a 9
M
For g(Y) = oY
Y2 
1 +  Y 2  »
g '(Y) = - j — Y + a -  y 2^2 • At Y = 0 an approximation for g(Y) using Taylor
polynomials isg'(0)(Y -  0) = 6TY and at each real root lq, g '(k; )(Y -  k ;) for i = 1,2,3
represents the other three approximations. If all three roots are real, we have two 
unstable fixed points and two stable fixed points, (see Figure 18). If we define the four
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real roots as 0 , k„ k^ and k3 then according to Strogatz [39], k2 and k3 approach each 
other and eventually coalesce in a saddle-node bifurcation when k2 = k3. After the 
bifurcation, the only remaining fixed point is kt (in addition to 0 of course). Similarly k, 
and k2 can collide and annihilate as a" is increased. Thus, for three positive fixed points, 
the smaller stable fixed point kt is called the refuge level of the budworm population or 
in our case the cancer population, while the larger stable point k3 is the outbreak level. 
From the point of view of pest control i.e. cancer control, we would like to keep the 
population at k, and away from k3. The fate of the system is determined by the initial 
condition Y0. Thus an outbreak occurs if and only if Y0 > k2. In this sense the unstable 
equilibrium k2 plays the role of a threshold. An outbreak can also be triggered by a
saddle-node bifurcation. If the parameters of and p drift in such a way that the fixed
point k, disappears, then the population will jump suddenly to the outbreak level k3. The 
situation is made worse by the hysteresis effect-even if the parameters are restored to 
their values before the outbreak, the population will not drop back to the refuge level. 
The condition for a saddle-node bifurcation is that k2 coalesce with k3 This can
also be described as that condition where the line a '  Y'
lT .
intersects the curve
Y dg
— ~Y tangentially (see Figure 19 and Figure 20). Thus both g(Y) = 0 and 7 7  = 0 .
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0 .5
s2 ( y )
s3 ( y )
y
Figure 19: Tangential intersection of g(Y) = 0 i.e. k, = k3.
g(y)
y
Figure 20: k2 = k3 which creates the tangential effect in Figure 19. The parameter value 
used in both Figures 19 and 20 are cT = .465 and 0=8 .
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Substitution of a  / p into g(Y) = 0 results in the expression
2 Y
a  =
( l + Y 2)
Substituting equation (36) into equation (35) yields
-  2Y
P = Y '-  1
Thus p > 0 implies that Y is restricted to Y > I. Together equations (36) and (37) 
define the bifurcation curves. For each Y > 1, we can plot the corresponding point 
P and of in the (P,o") plane (see Figure 2 1 ).
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Outbreak
0.6  - -
Bistable
Refuge
Figure 21: Together equations (36) and (37) define the bifurcation curves. For each 
Y > 1, we can plot the corresponding point p and a  in the (P ,cT) plane.
The different regions in Figure 21 are labeled according to the stable fixed points 
that exist. The refuge level k, is the only stable state for low cT, and the outbreak level
k3 is the only stable state for large cT. In the bistable region, both stable states exist.
The stability diagram can be regarded as the projection of a cusp catastrophe surface, as 
seen in Figure 22.
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refuge
a
Figure 22: Cusp catastrophe surface.
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TRAVELING WAVE SOLUTION
Again let us begin with equation (30) this time on the whole real line and 
approximate g(Y) defined by equation (33) to 0(Y2) . Simplifying we obtain
3Y —dzY _ f l  01- -- Yla  pj (38)
In 1937 Fisher considered a population of individuals carrying an advantageous allele of 
some gene a and migrating randomly into a region in which only the allele A is initially 
present. I would like to adapt his equation from Edelstein-Keshet [8 ] in which she gave 
an analysis of his equation. In this framework we assume Y to be the frequency of cancer
cells in the population of cells and f i  01- Y
la  P) the frequency of immune cells
Assume a traveling wave solution Y(x,r) = Y(w) where w = x - vr and w  6  ( -  oo ,oc) 
We can then write an ordinary second order differential equation
dw
- D d 2Y a
' 1 + 1
v dw2 v
1-
.a  p,
Y (39)
Define
dY
dw = -Q
(40)
then, equation (39) becomes
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Consider a YQ plane corresponding to the system of equations (40) and (41). First we 
deduce the nullclines.
Q = 0 (Y nullcline)
Q = - Y  
v
f 11 - " -- Y
l a  pj
(Q nullcline)
(42)
(43)
Next we find their intersection (i.e. the steady states). These are (Yj Q,) = (0,0) and
(Y^Ch) =
< ap '  
a + P ’°
The Jacobian of equations (40) and (41) is
■
a 2a
T 5 ' ~ W
'  0 - I
- a - v
n r ZT.
- 1
1 1  - v
-  + =  \ Y which at (0 ,0 ) is
'  0 -T ( -7T \ ap
-  T>°a -v and at
~T). l a  + p )
is
. This makes (Y[ Q,) a stable node and (Y^Qj) a saddle point provided
v > 2(aD) . The YQ phase plane is shown in Figure 23. On this figure arrows
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correspond to increasing w values, since w is the independent variable in equations (40) 
and (41). A single trajectory emanates from the saddle point and approaches the node as 
w increases from - to A trajectory that connects two steady states is said to be 
heteroclinic. Such trajectories have special significance to our analysis, as will presently 
be shown.
(Y„ Q,)
Figure 23: Traveling wave solutions to equation (38) satisfy a set of ODE’s (equations 
(40) and (41)) whose phase-plane diagram is shown here.
Figure 24 shows a traveling-wave solution to Fisher’s equation (38). The 
heteroclinic trajectory shown connecting the two steady states (Y^Q,) = (0 ,0 ) and
W 1Q2) = ' = ? ya  + p ,
a Pis the only bounded positive trajectory. Since Y(w)- ——=  for
a  + 3
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w  —  «  and Y(w) -  0 for w -*  oo
To interpret Figure 24 in light of propagating waves we must first recall the 
interpretation given to the functions Y(w) and Q(w). Forfeiting a role previously played 
by time, the variable w stands for distance along the length of a wave. Any one curve in 
the YQ plane thus depicts the cancer frequency Y and its spatial variation Q from one 
end of the wave (w  =  - oo) to the other (w = oo). We are primarily interested in the 
former, Y(w). However, not all the phase plane trajectories give reasonable depictions of 
a biological wave. We consider the heteroclinic orbit mentioned above and observe the 
following properties of this curve:
a B
Y (w )= Y 2 = ^ =  ( w -  - -°) 
ct + p
Y(w)= Y, = 0 (w -  oo)
Y, < Y(w) < Y2 ( -  oo< w < oo)
A sketch is given of these qualities in Figure 24. This wave has the shape of a moving 
front. At large positive w, Y(w) is very small (approaching zero for w -  oo), whereas at
c l P oTB
large negative w values Y(w) is very close to _  — (approaching ——=  for w -  - oo).
a + P  a + p
This means that the spread of cancer cells has become dominant at the left part of the 
domain, whereas it has become subdued towards the right.
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Y(w)
Y (w )
P
Pa-b
w
oTBFigure 24: The qualitative shape of the wave. Y(w)- ——-  for w -  -«> and Y(w) -  0 as
a  + p
w -  +80. The direction and speed of the motion is indicated.
If A equals the Jacobean matrix for equations (40) and (41) evaluated at each of 
the steady states, then the conditions for a stable node are:
B < 0 and y > 0  where B = Tr A  and Y = det A. Tr A = -v/D < 0 , thus B < 0  and 
Det A = a/D > 0, thus y > 0. Hence (0,0) is a stable node. A saddle point is defined 
when y < 0. In this case y = -a/D, and B = -v/D. The disc A = B2 - 4 y must be 
positive for the eigenvalues to be real numbers, thus B2 > 4 y implies
v /^D2 > 4 a/D, v2 > 4aD or v > 2 v a D  . Thus the wave shown in Figure 24 must
move at speeds that exceed the minimum velocity 2 yjaD .
Adam [40] sites the lower bound on wave speeds for wavefronts linking stable 
tumoral states to unstable cancer-free states as 2 x I O'7- 2 x I O'8 cm/sec corresponding to 
a tumor of size 1 cm being established in 50-500 days (depending on the value of the 
diffusion coefficient).
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CHAPTER VD 
TUNNELING
“If an idea is not outrageous to start with, then it probably 
wasn’t a good idea to begin with.” Attributed to Albert Einstein
According to Lowden, [37] there is little doubt that many of the fundamental 
biochemical processes in living systems are directly connected with the transfer of 
electrons and protons. Since these are fundamental particles which do not obey the laws 
of classical physics but the laws of modem quantum chemistry, the electronic and 
protonic structure of biologically interesting molecules and systems has to be treated by 
quantum chemistry. This has led to the opening of a new field which has been called 
submolecular biology or “quantum biology”. After a DNA replication, the protons are 
necessarily in nonstationary states which implies that there is a certain probability for 
“quantum jumps” which will lead to discontinuous changes of the code which will 
become apparent at the next DNA replication. This mechanism may be responsible for 
the occurrence of spontaneous mutations, the phenomenon of aging considered as a loss 
of useful genetic information, and the spontaneous occurrence of tumors (and cancer) as 
a consequence of somatic (or bodily) mutations depending on the accumulated effects of 
code changes in a certain direction. We try to understand these ideas by considering a 
simple model of “tunneling”.
Lowden [36] states: In the tunnel-effect discovered by G. Gamow, and Gurney
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and Condon, a quantum-mechanical particle having mass m and energy E may penetrate 
a classical potential barrier V = V(x). From Baym [33] particles can penetrate into 
regions that are forbidden classically. This means that even though a classical particle 
would be unable to penetrate a barrier, a quantum mechanical particle incident from the 
left has a certain probability of being found to the right of the barrier. If we consider a 
potential barrier of height V over [0,a] and if E represents an energy state such that 
E < V then a mathematical model illustrating this phenomenon is
f W  =
Ae"*,h + Be'*"*,* < 0 
Ce~b + Dek,0<x < a 
AS(E)e‘p'x- v\x>a
where \|/ (x) is derived from the time independent Schrodinger equation
ih 3\|/(x,t) - h 2 a 2\|/(x,t) T„  N
 -------1 = - --------—;— + V(x)u/(x, t) . . .
2k dt 4k m dx with boundary conditions.
The function S(E) is called the tunneling matrix element or transmission amplitude. It is 
essentially the probability amplitude for the process that a particle incident on the left 
with energy E will tunnel through the step. For E <V,
S(E) = ------ Ti— T T T 1—. 2, .  wfiere p =yJlmE ,4ikphxcoshka + (4k p -  h k )sinhka
hk = 2k V2m (V- E) and m represents the mass of the particle, and h is Planck’s
constant. The probability that a particle striking the barrier from the left will tunnel 
through to the right, is given by
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T(E) = |S|2 =
(as is shown in standard texts on quantum mechanics, e.g. Schiff [41]). In a similar 
manner, cancer is made up of many “particles” (cells) that obviously would not exist if 
the immune system were 100% effective. While indeed the immune system may kill 
some or all of the invading cancer cells, (i.e. by acting as a barrier to the cancer growth), 
sometimes the cancer evades the immune response mechanism and subsequently 
prevails. In this light, we borrow the idea of quantum tunneling to examine the 
cancer/immune system response from a somewhat novel perspective, noting that the 
cells are macroscopic quantities (compared with atomic particles) and so the relevant 
mathematical model contains no reference to h and m. Nevertheless, the methodology is 
similar; an eigenvalue problem can be posed for the effective “transmissivity” of the 
immune system.
THE MATHEMATICAL MODEL
Let Xj represent the number of cells in a malignant tumor. We would expect that 
Xc would be no more than O(1013) which is the approximate number of cells in a human 
being. A tumor may be palpable when the number of cells is of 0(10®) ( as occurs for
example in the breast area). Thus, instead of using x,. as the independent variable, it
sinh2 ka 
+ 4 (£  I V ) ( \ - E I V )
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would seem more natural to use x  = log x,. as our independent variable. Let V  ( x  ) be
the measure of the host immune response to tumorigenesis, i.e. the beginning of a tumor. 
Next assume x  is defined on [0,xj where x,„ =13 on the log scale or 1013 on the
X
original scale. Rescale [0 ,x j onto [0,1] by using a new variable x= —  . We will
assume a barrier interval [p,q] of width q - p and height V(x) where [p,q] is contained 
within the interval [0,1]. We might think of the width of the barrier as a measure of the 
efficiency of the immune system in preventing “leakage” from a state of low cancer cell 
number to a correspondingly higher (and dangerously so) state. The height of the 
barrier can be thought of as a measure of the aggression of the cancer, insofar as a 
higher barrier can contain more “ levels” of cancer aggression (i.e. more energy levels).
It is as if the cancer interacts with the immune system (which it does) to induce a yet 
higher level of aggression which may not be present in lower barriers. Of interest would 
be to take a barrier of given height (such that there are at least two eigenvalues, and 
progressively widen the barrier, keeping the height constant, to see how the 
eigenfunctions (and hence probabilities) change across the barrier.
Consider the one-dimensional “Schrodinger-type” equation for the cancer cell 
population in a steady-state
£ j r + [ i - V ( x ) ] y = 0  (52)
where y(x) is the probability amplitude of cancer being found at location x. Here ^ is
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an eigenvalue representing the energy or “progression” of the cancer cells towards a 
highly malignant and dangerous state, while V(x) is the height of the barrier (i.e. V is 
constant).
The boundary conditions are
• y(l) = 0  ( no cancer beyond this maximum value of x = 1)
• for some parameter a, such that 0  < a  < 1 , a  y (0 ) -  (1  -  a  )y ' (0 ) = 0  ,and
• y and y '  are continuous at p and q
I |2The first two conditions follow from the fact that we are assuming that |y| is equal to
the probability of the system (host) being found at “location” x. The last condition is 
required for purposes of continuity. In addition V = 0 outside the interval [p,q] and
J* |y| = 1 . The solution of equation (52) is 
o
Asin(V^x) + Bcos( VaTx) for 0 < x < p V = 0 (53)
y=  < N e Vv“Xx+ M e vV for p < x < q  and V > \ (54)
Fsin(V T)x+G  cos(V^T)x for q < x < 1 V = 0 (55)
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1 -  a
Let k  = yfk , h = -yjV -  X , and (3 =  then the constants for equation (53) are
a
A = (A1 + A2 + A3 + A4  + A5) where
A1=Ik
( k 2p2 -  l)sin(2kp)
+ k (k 2p2p + 2p + p) -  2kp cos2(kp)
A2 =
1 N l2e(4hq) -  Ml2 + 4NlMle(2hq) hq
2  e(2hq) h
A3= -
(N l2e(4hp) -  Ml2 + 4NlMle(2hp)hp)
e{2hp) h
A4 =
FI2
2k
(tan2 k - 1) sin 2k
+ ktan2 k+ k + 2tankcos2 k
A5 =
FI2
2 k
(1 -  tan2 k )sin 2 kq
-  kqtan2 k -  k q -  2 tankcos2 kq
and B = Akp. The constants for equation (54) are M = Ml- A and N = Nl-A,
-kQ 3coskp+ 04sm kp , k01coste+ 02s\nkpwhere M l = — =--------------  and N 1 = — ------— -------—
2 h e p 2 hehp
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
84
The constants for equation 55 are:
kQlcoskp + Q2sinkp h,„ .
F = A ------------- ----------- — - --------   e q_p) (56)
( k - h  tank) cos kq+(h+k tank) sin kq
where Q l=  1+ph,  Q2  = h - k 2p , Q3= l - p h , a n d  Q4 = h+ k2p
and G  = -  F ta n k  . Also, in solving we find that F must also equal equation (57)
r _ A Q4sinkp-kQ3coskp ck|p-,) (57)
(h - ktank)sinkq- (k+ htank)coskq
An eigenvalue problem is a boundary value problem that has nontrivial solutions only 
when a parameter X has special values called eigenvalues. In order for this problem to 
have solutions equation (56) must equal equation (57). Rewriting equation (56) in terms 
of X we obtain:
vr(i-pvv-x)cosvrp+(yv-x +pa.)smvrp
1 (Vx-  V v^T  tanVT)cosVUi+ (V v ^ I  + VT tanVT)sinVTq 6
and for equation (57) in terms of X we obtain:
(W - X -  PX)sinVTp- VTd- PVy - X jcosVTp vv^ (P-q) 
2 (VV-X -  VTtan-\/X)sinVXq-(V^" + V V -1 tanVk )cosVkqC
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Setting fi(A) = f2(A.) and rewriting, we obtain two functions to be called f3(A.) and 
f4(A) defined as follows
f j O )  = e ‘"/^ :(q~l>) , (58)
(VV-X + 3 J . ) s i n V j T p - V X ( l - P i / v ^  A.)cosVTp 
f  = (VV-Jt  - ( U ) s m V T p  + V U l+ P V V - A .  )cosV^P
. (V Y - X + y/X tan-v/rjsinVTq-f (V T - V V - X tanVAOcosVTq
4( )= ( (VV-X -  <A tan«A) sinVTq- (VT + VV -  X tanVx~)cosVTq
The parameters needed to graph f3(A.) and f4(X) are the height V, and position of 
the width, p and q. For example, for p = .6 and q = .8 with a height of V = 4 the graph 
of equations (58) and (59) are given in Figure 25.
As observed in Figure 25, for each barrier there always exists at least one 
eigenvalue namely X = V, but there may not exist an eigenvalue X < V for all heights V. 
As we will see, for some larger values of V it is possible to obtain more than two 
eigenvalues less than V. A graph of the function y from equations (53), (54) and (55) for 
a = .3, X = 3.61, V = 4, p = .6  and q = .8 is given in Figure 26. The graph of the square 
of the function y is given in Figure 27 for the same barrier values as given above in 
Figure 26. Following Figure 26 are various other figures depicting different 
immune/cancer responses. At the conclusion of the figures there is a table of 
eigenvalues for various values of a , V, p, and q.
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3
2.5 3 3.5 4
X
Figure 25: f3 is represented by the solid line, and f4 by the dotted line. You can see the 
intersection at V = X. Our interest is in the X < V. In this graph a = .3,
V = 4, p = .6 , and q = .8 . The intersection of f3 and f4 is at X =3.61.
5
y t(x )  4
3
2
0
0.4 0.60 0.2 0.8 1.2I
x ,x 2 ,x 3 ,z ,z l,x 2
Figure 26: The function yl,y2, and y3 forms the three pieces of the function y from
equations (53), (54), and (55). y6 , y7,and y4 forms the rectangular barrier. 
The parameter values are identical to those used in Figure 25.
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y l(x ) 4 _
y6(z)
y7(zl)
0.2 0.6 0.80.4 1.2
x .x 2 ,x 3 ,z ,z l,x 2
Figure 27 : This is the square of the function y of Figure 26.
-100
Figure 28: V = 26, a = .5, p = .2 and q = .4. This produces two eigenvalues as shown 
above. The first = 11.1 and the second X2 = 25.77.
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3
0
0.6 0.80 0.2 0.4 1
x ,x 2 ,x 3 ,z ,z l,x 2
Figure 29: V = 26 and A, = 1 1.1, p = .2, and q = .4. The immune system does not 
appear to affect the cancer significantly.
3
y6(z)
0 0 0.2 0.4 0.6 0.8 1
x ,x 2 ,x 3 ,z ,z l,x 2
Figure 30: The graph of y2 corresponding to Figure 29.
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0.4 0.6 0.S0.2
x ,x 2 ,x 3 ,z ,z l,x 2
Figure 3 1: V = 26, and X2 = 25.77, a, p, and q as in Figure 28. Now the immune barrier 
prevents the cancer from tunneling through.
3
y l(x )
0
0.60 0.2 0.4 0.8 I
x ,x 2 ,x 3 ,z ,z l,x 2
Figure 32: The graph of y2 corresponding to Figure 31.
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Figure 33: V = 30, a = .4, p = .5 and q = .55. The graph shows two eigenvalues which 
are = 5.03 and X2 = 25.1.
y l(x )
y7(zl)
0.5
0.80.2 0.4 0.6 1.2
x ,x 2 ,x 3 ,z ,z l,x 2
Figure 34: V = 30, a = .4, p = .5 and q = .55. This graph was formed using the 
eigenvalue ^  = 5.03.
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
91
yiCx)
y4(x2)
0.2 0.4 0.6 0.8 1.2
x ,x 2 ,x 3 ,z ,z l,x 2
Figure 35: The graph of y2 corresponding to Figure 34.
y l(x )
y7(z l)
0.5
0.2 0.4 0.6 0.8
x ,x 2 ,x 3 ,z ,z l,x 2
Figure 36: V = 30, a = .4, p = .5 and q = .55. This graph was formed using the
eigenvalue X2 = 25.1. It would appear that the cancer tumor was destroyed 
for reasons other than the presence of the immune barrier.
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y l(x )
0.2 0.6 0.80.4
x ,x 2 ,x 3 ,z ,z l,x 2
Figure 37: The graph of y2 corresponding to Figure 36.
l . i
1.05
2.85 2.952.9 3
I
Figure 38: V = 3, a  = .01, p = .3, q = .4. The eigenvalue is 2.92.
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y6(z)
0.2 0.4 0.6 0.8
x ,x2,x3,z,zl,.x2
Figure 39: The graph of y for V = 3, a = .01, p = .3, q = .4. The eigenvalue is 2.92
3
y l ( x )
y6(z)
y7(zl)
I
0 0 0.2 0.4 0.6 1.20.8
x ,x 2 ,x 3 ,z ,z l,x 2
Figure 40: The graph of y2 corresponding to Figure 39.
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Figure 41: This graph represents the special case when a = 0 V = 3 and p = .7 q = .8 . 
The eigenvalue is 2.55.
3
y l(x )
2
y3(x3)
y 7(z l) i
0
0.20 0.60.4 0.8 1 1.2
x ,x 2 ,x 3 ,z ,z l,x 2
Figure 42: This is the graph of y2 for a  = 0, V = 3, p = .7, q = .8 and k = 2.55.
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Table 8. A Table of Eigenvalues
a V P q A
.01 4 .2 .3 3.157
.01 4 .2 .4 3.721
.01 5 .2 .5 4.57
.01 6 .2 .7 6.428
.01 3 .5 .6 2.734
.01 3 .5 .7 2 .8 8
.01 3 .5 8 2.95
.01 3 .7 .8 2.57
.01 3 .7 .9 2 .6
.01 24 .2 .3 6.19, 23.1
.01 24 .2 .4 9, 23.2
.01 27 .2 .5 12.2, 24.42
.01 27 .5 .6 4.26, 26.1
.01 27 .7 .8 3.0843, 26.25
.01 76 .7 .8 3.6255, 31.18, 75.7
.3 4 .2 .3 3.917
.3 5 .2 .4 4.805
.3 6 .2 .5 5.8027
.3 8 .2 .9 8.52
.3 4 .5 .6 3.614
.3 4 .5 .7 3.833
.3 5 .5 .8 4.1
.3 4 .7 .8 3.38
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Table 8 Continued
a V P q X
.3 4 .7 .9 3.42
.5 6 .2 .3 5.08
.5 6 .2 .4 5.977
.5 8 .2 .5 7.595
.5 11 .2 .7 10.52
.5 13 .2 .9 11.97
.5 5 .5 .6 4.62
.5 6 .5 .7 5.06
.5 6 .5 .8 5.23
.5 5 .7 .1 4.28
.5 5 .7 .9 4.35
1 12 .2 .3 10.95
I 13 .2 .4 12.73
1 17 .2 .5 16.23
1 35 .2 .7 34.72
1 74 .2 .9 73.74
I 13 .5 .6 12.26
1 15 .5 .7 14.6
1 17 .5 .8 16.23
1 12 .7 8 10.95
1 12 .7 .9 11.32
.8 8 .2 .3 7.72
.8 10 .2 .4 9.498
.8 12 .2 .5 1 1 .8 8 6
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Table 8 Continued
a V P q A
.8 21 .2 .7 20.492
.8 25 .2 .9 24.01
.8 8 .5 .6 7.68
.8 9 .5 .7 8.56
.8 10 .5 .8 9.16
.8 8 .7 .8 7.06
.8 8 .7 .9 7.19
0 4 .2 .3 3.14
0 4 .2 .4 3.7
0 5 .2 .5 4.55
0 7 .2 .7 6 .2
0 7 .2 .9 6.4
0 3 .5 .6 2.719
0 3 .5 .7 2 .8 6
0 3 .5 .8 2.93
0 3 .7 .8 2.55
0 3 .7 .9 2.57
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CONCLUSION ON TUNNELING
As the table and graphs show, there are many models for the many situations that 
are possible in the cancer/immune relationship. While we use terms like “aggressive”, or 
“slow” to describe certain types of cancer, at present there is no numerical value 
associated with cancer progression. In this model, in forming the table, the 
“minimum” values were sought, i.e. in terms of whole number quantities, which would 
produce an eigenvalue. For example, for a = .01, and p = .2 and q = .3 a barrier height 
of 4 was the first whole number which produced an eigenvalue X < V. Naturally, we 
would be interested in knowing more about the circumstances which lead the immune 
system to triumph over the cancer as in Figure 29. From a mathematical standpoint, 
Figure 29 seems to occur in similar circumstances, i.e. a large height which permits two 
eigenvalues less than V and the eigenvalue closest to V being the value producing the 
result of immune barrier stopping the cancer. Wide barriers, implying the immune 
system is very effective, also induce a decline in the probability that cancer is present. 
This is obviously just a beginning in the modeling of cancer and the immune system from 
this perspective and much more remains to be done. One significant question concerns 
the validation of this type of model: how can this be done? The present results are 
suggestive that the “immune barrier” may be a useful metaphor for tumorigenesis, but to 
bring it down to the level of a model it must be predictive and testable. In this 
dissertation, a start has been made on the “metaphorical” aspect of the problem. 
Tumorigenesis is based on the notion that developing tumor cells acquire an ever-
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increasing growth advantage through gene mutations. These mutations create genetic 
variability; the cells with the most growth-favoring mutations proliferate rapidly, 
outcompete normal cells, and soon dominate. But to survive a tumor cell must also 
defeat the host’s defenses and become an effective parasite. Accomplishing this may 
depend upon its abilities to evade immune surveillance, to metastasize, and to attract a 
blood supply. The importance of immune defenses against cancer is a matter of 
controversy. One school of thought argues that specialized cells of the immune system 
continuously survey tissues for small nests of tumor cells that, once recognized, are 
attacked and wiped out. This view is supported by the discovery of natural killer 
lymphocytes that seem able to identify and destroy many types of tumor cells. Tumor 
cells may display specific antigens on their surfaces that alert the immune system to their 
presence. Tumors more than a few millimeters in diameter soon stop growing unless 
they have a blood supply. If immune surveillance by these and other cell types is indeed 
important in antitumor defenses, then cancer cells must acquire an ability to elude the 
immune system [38],
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APPENDIX A 
COMPARISONS OF THE AREAS OF THE 8-WIDTHS 
AND THE RADIUS OF THE WOUND
In Model I and II of the two-dimensional case in wound healing, and in the 
three-dimensional case, the critical 8 -region is found by approximation, and in each case 
is found to be dependant on the original wound size R. Figure 2, Figure 10, and Figure 
15 show monotone decreasing functions which imply that as the wound size R increases 
the 8 -values decrease. At first this may seem to be a contradiction to logic, i.e. that 
large wounds require smaller 8 -band widths. However, by comparing the area of the 8  
band width with the radius of the wound size we obtain the following formula
8 -Area(R) = tt(2R 8  + S2).
After non-dimensionalizing the area formula and substituting the minimum 8  values 
found we have the following equations.
For the two-dimensional Model I
Area(Y) = it nK0(Y) I nK,j(Y)J J
whose graph is Figure 43 for n = 3.
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
105
10
8
A(Y) 6
4
2 0 31
Y
Figure 43: The graph of the area function for the two-dimensional model I and n = 3.
to
A2(Y) 5
0 0 I 2 3
Y
Figure 44: The graph of the area function for the two-dimensional model II and n = 3.
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For the two-dimensional model II the area equation is
Area(Y) = k
^2Y nYK0(Y)IO(Y) I nYKo(Y)I0(Y)j
and the graph is given in Figure 44. For the three-dimensional model the equation is
Area(Y) = n
f  Y + l
f Y+ l)
2^
2 ------ +
I nY JV n y
and the graph is given in Figure 45.
10
8
A3(Y) 6
4
2
Y
Figure 45: The graph of the area function for the three-dimensional model and n = 3.
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
107
The graphs of these three functions are all similar showing an almost parabolic shape 
with a relative minimum value beyond which the area of the 8 -region is increasing as Y 
gets larger.
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APPENDIX B 
JUSTIFICATION FOR THE CHOICE OF THE 
APPROXIMATION FUNCTION OF 0 (e 3)
In the three -dimensional model e* was approximated to O(e') but the 
approximation yielded no useful information. Even approximations (i.e. 0 (e2) etc.) 
yield functions which are monotonically decreasing and thus do not give the 
information needed (see Figure 46).
The approximations for e* are as follows:
Y + 1 Y + 1 l f K + 1 ' 2
O(e'): 1 - —  ; 0(e3): 1 - — — + -nY nY 2\ nY and
Y+ 1 l(Y+\)2 \(Y+ l V  
6 V nY;
The graph of 0(e2) is given in Figure 46.
Since these are only approximations and for m a positive integer 0(e2ra) gives 
rise to monotonically decreasing functions while 0 (e2m+1) produces monotonically 
increasing functions (the kind of approximation needed for our study) the choice 0 (e3)
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was made because it was also solvable and higher odd orders would have been more 
difficult or impossible to obtain explicitly.
4
0(Y )
2
0 0 0.5 1 1.5 2
Y
Figure 46: The graph of the approximation function to 0(e2) .
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APPENDIX C 
DETAILS ON MODIFIED BESSEL FUNCTIONS AND 
DERIVATION OF SELECTED FORMULAS WITHIN THE TEXT
The modified Bessel functions used in the text were I0, Ib Ko, and K, These 
functions are defined as follows:
I0(x) = J0(/x) where J0 is a Bessel function. . = I. (x)
dx
%
Ko(x)=lim 
p-> o  2
I -p (x ) - Ip(x)
sin(pTt)
d(K0(x))
and   ------ = -K.(x)dx
These functions satisfy the differential equation x2y" + xy' -  (x2 + n2)y = 0
for n = 0  or 1.
The Asymptotic Expansions (which were used to find the limits for large y values in 
Model I and Model II) for each of the four functions are as follows:
r , . ex L  1 9 75I0 (X)» rz---- \ 1+ — + TTT-T +
J i n x  [ 8x 128x2 1024x3 "j
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The graphs of the four functions are below.
10
5
0 0 4
X
Figure 47: The top graph is I0(x) and the bottom graph is Ij(x).
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10
5
K l ( x )
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Figure 48: The top graph is Kt(x) and the bottom graph is Kq(x).
The wronskian identity is I„(x) K,(x) + I,(x) Ko(x) = l/x.
DETAILS OF THE ONE-DIMENSIONAL MODEL
In the one-dimensional model, the solutions were hyperbolic functions. In this
model the wound edge is L/2. Thus c [y ]  >9 was examined for Model I which
assumes no bone remains in the wound area. The 6 -region was found to be only 
dependant on n, i.e. 5 e = ln^y—y j where n is defined in the same manner as the two
and three dimensional models. No result was given for L-critical in Model I. In
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Model II, a solution for L-critical is obtained in terms of the width of the growth factor
region, 8 , namely Lc = a 1 In-
2 - n ( l - e - “fi)
DERIVATION OF C(r) FOR THE TWO-DIMENSIONAL CASE MODEL I 
Since x = aR, we can write the solution in terms of aR. Thus,
C^r )  = AI0( a r )+BK 0(ar) + — f o r R ^ r s R  + 8  and
A,
C2 ( r )=  FI0 ( a r ) + G K 0 (ar)  f o r r > R  + 8 .
The boundary condition = 0  gives us B = A ■ . The boundary condition
dr K,(aR)
lim C (r) = 0 tells us that F = 0 since I0(aR) is an increasing function. K^aR)
approaches zero for large x. Thus C2(r) -  GK0( a r ) . The last boundary condition
, • • .  ,  dC(r)(contmuity at R + 8  for C and — -— ) will allow us to find A and G.
dr
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A I0 (a  (R  + 8 )) + B K 0(a  (R  + 5 ))  + -  = GK 0(a  (R  + 8 )) and
K
AIj(a(R+ 8 ) ) - BKj(a(R + 5 )) = GKj(a(R+8)).  Rearranging the terms
and substituting our solution for B, we obtain the system
a [ I 0(a(R+ 8))+ ^ 7^ : K : 0(a(R+ 8)] -  GK0(a(R+ 8)) = -  f  and
V K.,(aR) y/ A.
I1( a ( R +  5 ) ) -  ^ ^ Ki ( a ( R +  «) + G K , ( a ( R + 5 ) ) = 0
-t^ K ^ o CR + S))
Using determinants A = 7--------------v-------------  and
(l0Kl + IlK0X a(R +8))
G =
P
X I1( a ( R + 5 ) ) - | ^ K , ( a ( R + S ) )
( l0K 1 + I lK0 )(a (R  + 8 ))
Similar method were used to
derive Model II and the three-dimensional model.
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